FDA Added to Innovative E&L USA 2020 Program

The FDA has been added to the agenda for Smithers’ 9th Extractables and Leachables USA Conference, taking place in Bethesda, MD, April 20-22, 2020.

Alan Hood, Research Toxicologist at the Center for Devices and Radiological Health, FDA, is joining expert presenters from Baxter International, Inc., Intertek, Becton Dickinson, ELSIE, D&B ChemTox, LLC, Nelson Labs, APS, SafeBridge Consultants, SGS, Jordi Labs, PPD, and more.

Hood is presenting on establishing a standard approach for assessing toxicological risk of medical device constituents. He will cover the development/content of ISO TS 21726:2019 on the application of threshold of toxicological concern for medical device, and the future direction of ISO 10993-17.

The 2020 program focuses on top industry influencers, including safety assessment strategies, analytical challenges in E&L profiling: quantitation and identification, regulatory updates, the global landscape, the role of chemical characterization in establishing the biocompatibility of medical devices, analytical advances, and case studies.

The Industry insight and valuable connections made at this event push the extractables and leachables industry forward and provides attendees with the information needed to confidently and securely grow their businesses.

The earlier you register, the more you save. Visit the event website for more information. Contact Producer Ashli Speed with questions about the program; Starla Ford for help with registration; and Shannon Siegferth to showcase your brand at this leading event. To get the latest updates, follow the event on twitter @SmithersELEvent, join the LinkedIn group Extractables and Leachables Forum,